WASHINGTON TRUST Co raised its stake in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 3.0% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 83,840 shares of the pharmacy operator’s stock after buying an additional 2,422 shares during the period. WASHINGTON TRUST Co’s holdings in Walgreens Boots Alliance were worth $6,759,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Walgreens Boots Alliance by 2.3% in the second quarter. Vanguard Group Inc. now owns 60,289,046 shares of the pharmacy operator’s stock worth $5,020,269,000 after buying an additional 1,371,240 shares in the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in Walgreens Boots Alliance by 0.7% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 22,365,047 shares of the pharmacy operator’s stock worth $1,862,337,000 after buying an additional 159,480 shares during the last quarter. Capital World Investors raised its stake in Walgreens Boots Alliance by 11.5% in the second quarter. Capital World Investors now owns 19,625,115 shares of the pharmacy operator’s stock worth $1,634,183,000 after buying an additional 2,028,252 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Walgreens Boots Alliance by 7.2% in the second quarter. Bank of New York Mellon Corp now owns 13,003,529 shares of the pharmacy operator’s stock worth $1,082,804,000 after buying an additional 874,011 shares during the last quarter. Finally, BlackRock Fund Advisors raised its stake in Walgreens Boots Alliance by 0.3% in the second quarter. BlackRock Fund Advisors now owns 10,025,282 shares of the pharmacy operator’s stock worth $834,805,000 after buying an additional 28,004 shares during the last quarter. 58.93% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded down 0.58% during midday trading on Wednesday, reaching $85.03. The company’s stock had a trading volume of 4,111,518 shares. Walgreens Boots Alliance Inc. has a 52 week low of $71.50 and a 52 week high of $87.05. The company has a 50 day moving average of $81.44 and a 200-day moving average of $81.10. The stock has a market capitalization of $92.11 billion, a price-to-earnings ratio of 22.26 and a beta of 1.19.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.08. Walgreens Boots Alliance had a net margin of 3.56% and a return on equity of 16.33%. The company earned $28.60 billion during the quarter, compared to analysts’ expectations of $29.06 billion. During the same quarter last year, the company posted $0.88 EPS. The firm’s revenue was up .4% compared to the same quarter last year. Equities research analysts predict that Walgreens Boots Alliance Inc. will post $5.01 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be given a dividend of $0.375 per share. The ex-dividend date of this dividend is Tuesday, November 15th. This represents a $1.50 annualized dividend and a dividend yield of 1.75%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 39.27%.

WARNING: “WASHINGTON TRUST Co Has $6,759,000 Position in Walgreens Boots Alliance Inc. (WBA)” was published by Financial Market News and is the sole property of of Financial Market News. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of international copyright and trademark laws. The legal version of this piece can be viewed at http://www.financial-market-news.com/washington-trust-co-has-6759000-position-in-walgreens-boots-alliance-inc-wba/1210964/.

A number of analysts recently issued reports on WBA shares. Bank of America Corp. reiterated a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Tuesday, August 30th. Deutsche Bank AG boosted their price objective on Walgreens Boots Alliance from $93.00 to $94.00 and gave the company a “buy” rating in a research note on Tuesday, August 30th. Credit Suisse Group AG restated a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Monday, October 3rd. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $90.00 target price for the company in a report on Monday, October 3rd. Finally, Jefferies Group upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and upped their target price for the stock from $87.00 to $95.00 in a report on Monday, October 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $90.30.

In related news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the business’s stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $85.00, for a total value of $2,039,660.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Stefano Pessina purchased 2,000,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Friday, November 4th. The stock was bought at an average cost of $81.41 per share, with a total value of $162,820,000.00. The disclosure for this purchase can be found here. Insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc. (NASDAQ:WBA).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.